X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (16) 16
oncology (15) 15
female (7) 7
aged (6) 6
male (6) 6
middle aged (6) 6
adult (5) 5
cancer (5) 5
combined modality therapy (5) 5
pharmacokinetics (5) 5
animals (4) 4
antineoplastic agents - administration & dosage (4) 4
antitumor-activity (4) 4
carcinoma (4) 4
care and treatment (4) 4
chemotherapy (4) 4
clinical trials as topic (4) 4
neoplasms - drug therapy (4) 4
survival (4) 4
antineoplastic agents - therapeutic use (3) 3
aurora kinase a - antagonists & inhibitors (3) 3
azepines - administration & dosage (3) 3
colon-carcinoma (3) 3
head and neck neoplasms - therapy (3) 3
immunotherapy (3) 3
interferon-gamma - pharmacology (3) 3
mice (3) 3
pharmacology & pharmacy (3) 3
pyrimidines - administration & dosage (3) 3
tumor-infiltrating lymphocytes (3) 3
tumors (3) 3
united states (3) 3
abridged index medicus (2) 2
adenocarcinoma - drug therapy (2) 2
alisertib (2) 2
analysis (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - pharmacokinetics (2) 2
aurora a kinase (2) 2
azepines - pharmacokinetics (2) 2
biomarkers, tumor - metabolism (2) 2
carcinoembryonic antigen (2) 2
carcinoembryonic antigen - biosynthesis (2) 2
colonic neoplasms - immunology (2) 2
colonic neoplasms - therapy (2) 2
cross-over studies (2) 2
diagnosis (2) 2
dosage and administration (2) 2
dose-response relationship, drug (2) 2
drug dosages (2) 2
drug therapy (2) 2
gene expression regulation, neoplastic - drug effects (2) 2
genetic aspects (2) 2
growth-inhibition (2) 2
head and neck neoplasms - epidemiology (2) 2
head and neck neoplasms - pathology (2) 2
head and neck neoplasms - virology (2) 2
hematology (2) 2
hematology, oncology and palliative medicine (2) 2
histocompatibility antigens class i - biosynthesis (2) 2
immunology (2) 2
immunotherapy, adoptive (2) 2
infusions, intravenous (2) 2
interferon-gamma (2) 2
interleukin-2 - administration & dosage (2) 2
interleukin-6 - pharmacology (2) 2
killer-cells (2) 2
lung cancer (2) 2
lung neoplasms - metabolism (2) 2
lung-cancer (2) 2
medicine & public health (2) 2
melanoma (2) 2
mln8237 (2) 2
monoclonal-antibodies (2) 2
nci/fda workshop leading to the inception of "master protocols" in lung cancer (2) 2
neoplasms - metabolism (2) 2
neoplastic stem cells - drug effects (2) 2
oropharyngeal neoplasms - therapy (2) 2
overexpression (2) 2
papillomavirus infections - complications (2) 2
pharmacodynamics (2) 2
pharmacology (2) 2
pharmacology/toxicology (2) 2
phase-i (2) 2
protein kinase inhibitors - administration & dosage (2) 2
protein kinase inhibitors - pharmacokinetics (2) 2
pyrimidines - pharmacokinetics (2) 2
recombinant proteins (2) 2
research (2) 2
respiratory system (2) 2
review (2) 2
risk factors (2) 2
selective aurora (2) 2
signal transduction - drug effects (2) 2
small cell lung carcinoma - drug therapy (2) 2
small cell lung carcinoma - pathology (2) 2
surgery (2) 2
treatment outcome (2) 2
united-states (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 395 - 405
Journal Article
Head & Neck, ISSN 1043-3074, 12/2012, Volume 34, Issue 12, pp. 1681 - 1703
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 8, pp. 613 - 623
PURPOSEThe aim of this open-label, first-in-setting, randomized phase III trial was to evaluate the efficacy of alisertib, an investigational Aurora A kinase... 
BREAST-CANCER | APOPTOSIS | SIGNALING PATHWAYS | PHARMACOKINETICS | ONCOLOGY | KINASE INHIBITOR ALISERTIB | MLN8237 | AUTOPHAGY | AURORA KINASE | MESENCHYMAL TRANSITION | EPITHELIAL OVARIAN
Journal Article
Journal Article
International Journal of Clinical Pharmacology and Therapeutics, ISSN 0946-1965, 07/2015, Volume 53, Issue 7, pp. 563 - 572
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 02/2019, p. JCO1800899
The aim of this open-label, first-in-setting, randomized phase III trial was to evaluate the efficacy of alisertib, an investigational Aurora A kinase... 
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 03/2011, Volume 9, Issue 1, pp. 32 - 32
Progress in understanding the molecular basis of melanoma has made possible the identification of molecular targets with important implications in clinical... 
Journal Article